To include your compound in the COVID-19 Resource Center, submit it here.

Chiron, Matrix Pharma deal

CHIR will acquire MATX for $61 million.

Read the full 76 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE